Differential diagnosis

From Wikipedia, the free encyclopedia
https://en.wikipedia.org/wiki/Differential_diagnosis

In healthcare, a differential diagnosis (DDx) is a method of analysis of a patient's history and physical examination to arrive at the correct diagnosis. It involves distinguishing a particular disease or condition from others that present with similar clinical features. Differential diagnostic procedures are used by clinicians to diagnose the specific disease in a patient, or, at least, to consider any imminently life-threatening conditions. Often, each individual option of a possible disease is called a differential diagnosis (e.g., acute bronchitis could be a differential diagnosis in the evaluation of a cough, even if the final diagnosis is common cold).

More generally, a differential diagnostic procedure is a systematic diagnostic method used to identify the presence of a disease entity where multiple alternatives are possible. This method may employ algorithms, akin to the process of elimination, or at least a process of obtaining information that increases the "probabilities" of candidate conditions to negligible levels, by using evidence such as symptoms, patient history, and medical knowledge to adjust epistemic confidences in the mind of the diagnostician (or, for computerized or computer-assisted diagnosis, the software of the system).

Differential diagnosis can be regarded as implementing aspects of the hypothetico-deductive method, in the sense that the potential presence of candidate diseases or conditions can be viewed as hypotheses that clinicians further determine as being true or false.

A differential diagnosis is also commonly used within the field of psychiatry/psychology, where two different diagnoses can be attached to a patient who is exhibiting symptoms that could fit into either diagnosis. For example, a patient who has been diagnosed with bipolar disorder may also be given a differential diagnosis of borderline personality disorder, given the similarity in the symptoms of both conditions.

Strategies used in preparing a differential diagnosis list vary with the experience of the healthcare provider. While novice providers may work systemically to assess all possible explanations for a patient's concerns, those with more experience often draw on clinical experience and pattern recognition to protect the patient from delays, risks, and cost of inefficient strategies or tests. Effective providers utilize an evidence-based approach, complementing their clinical experience with knowledge from clinical research.

General components

Further information: Diagnostic procedure

A differential diagnosis has four general steps. The clinician will:

1. Gather relevant information about the patient and create a symptoms list.
2. List possible causes (candidate conditions) for the symptoms. The list need not be in writing.
3. Prioritize the list by balancing the risks of a diagnosis with the probability. These are subjective, not objective parameters.
4. Perform tests to determine the actual diagnosis. This is known by the colloquial phrase "to Rule Out". Even after the process, the diagnosis is not clear. The clinician again considers the risks and may treat them empirically, often called "Educated Best Guess."

A mnemonic to help in considering multiple possible pathological processes is VINDICATE'M:

• Vascular
• Inflammatory / Infectious
• Neoplastic
• Degenerative / Deficiency / Drugs
• Idiopathic / Intoxication / Iatrogenic
• Congenital
• Autoimmune / Allergic / Anatomic
• Traumatic
• Endocrine / Environmental
• Metabolic

Specific methods

There are several methods for differential diagnostic procedures and several variants among those. Furthermore, a differential diagnostic procedure can be used concomitantly or alternately with protocols, guidelines, or other diagnostic procedures (such as pattern recognition or using medical algorithms).

For example, in case of medical emergency, there may not be enough time to do any detailed calculations or estimations of different probabilities, in which case the ABC protocol (Airway, Breathing and Circulation) may be more appropriate. Later, when the situation is less acute, a more comprehensive differential diagnostic procedure may be adopted.

The differential diagnostic procedure may be simplified if a "pathognomonic" sign or symptom is found (in which case it is almost certain that the target condition is present) or in the absence of a sine qua non sign or symptom (in which case it is almost certain that the target condition is absent).

A diagnostician can be selective, considering first those disorders that are more likely (a probabilistic approach), more serious if left undiagnosed and untreated (a prognostic approach), or more responsive to treatment if offered (a pragmatic approach). Since the subjective probability of the presence of a condition is never exactly 100% or 0%, the differential diagnostic procedure may aim at specifying these various probabilities to form indications for further action.

The following are two methods of differential diagnosis, being based on epidemiology and likelihood ratios, respectively.

Epidemiology-based method

One method of performing a differential diagnosis by epidemiology aims to estimate the probability of each candidate condition by comparing their probabilities to have occurred in the first place in the individual. It is based on probabilities related both to the presentation (such as pain) and probabilities of the various candidate conditions (such as diseases).

Theory

The statistical basis for differential diagnosis is Bayes' theorem. As an analogy, when a die has landed the outcome is certain by 100%, but the probability that it Would Have Occurred in the First Place (hereafter abbreviated WHOIFP) is still 1/6. In the same way, the probability that a presentation or condition would have occurred in the first place in an individual (WHOIFPI) is not same as the probability that the presentation or condition has occurred in the individual, because the presentation has occurred by 100% certainty in the individual. Yet, the contributive probability fractions of each condition are assumed the same, relatively:

${\displaystyle \begin{array}{rl}& \frac{Pr(\text{Presentation is caused by condition in individual})}{Pr(\text{Presentation has occurred in individual})}=\frac{Pr(\text{Presentation WHOIFPI by condition})}{Pr(\text{Presentation WHOIFPI})}\end{array}}$

where:

• Pr(Presentation is caused by a condition in individual) is the probability that the presentation is caused by condition in the individual condition without further specification refers to any candidate condition
• Pr(Presentation has occurred in individual) is the probability that the presentation has occurred in the individual, which can be perceived and thereby set at 100%
• Pr(Presentation WHOIFPI by condition) is the probability that the presentation Would Have Occurred in the First Place in the Individual by condition
• Pr(Presentation WHOIFPI) is the probability that the presentation Would Have Occurred in the First Place in the Individual

When an individual presents with a symptom or sign, Pr(Presentation has occurred in individual) is 100% and can therefore be replaced by 1, and can be ignored since division by 1 does not make any difference:

${\displaystyle Pr(\text{Presentation is caused by condition in individual})=\frac{Pr(\text{Presentation WHOIFPI by condition})}{Pr(\text{Presentation WHOIFPI})}}$

The total probability of the presentation to have occurred in the individual can be approximated as the sum of the individual candidate conditions:

${\displaystyle \begin{array}{rl}Pr(\text{Presentation WHOIFPI})& =Pr(\text{Presentation WHOIFPI by condition 1})\\ & +Pr(\text{Presentation WHOIFPI by condition 2})\\ & +Pr(\text{Presentation WHOIFPI by condition 3})+\text{etc.}\end{array}}$

Also, the probability of the presentation to have been caused by any candidate condition is proportional to the probability of the condition, depending on what rate it causes the presentation:

${\displaystyle Pr(\text{Presentation WHOIFPI by condition})=Pr(\text{Condition WHOIFPI})\cdot r_{\text{condition}\to \text{presentation}},}$

where:

• Pr(Presentation WHOIFPI by condition) is the probability that the presentation Would Have Occurred in the First Place in the Individual by condition
• Pr(Condition WHOIFPI) is the probability that the condition Would Have Occurred in the First Place in the Individual
• r_{Condition → presentation} is the rate at which a condition causes the presentation, that is, the fraction of people with conditions that manifests with the presentation.

The probability that a condition would have occurred in the first place in an individual is approximately equal to that of a population that is as similar to the individual as possible except for the current presentation, compensated where possible by relative risks given by known risk factor that distinguish the individual from the population:

${\displaystyle Pr(\text{Condition WHOIFPI})\approx R{R}_{\text{condition}}\cdot Pr(\text{Condition in population}),}$

where:

• Pr(Condition WHOIFPI) is the probability that the condition Would Have Occurred in the First Place in the Individual
• RR_condition is the relative risk for condition conferred by known risk factors in the individual that are not present in the population
• Pr(Condition in population) is the probability that the condition occurs in a population that is as similar to the individual as possible except for the presentation

The following table demonstrates how these relations can be made for a series of candidate conditions:

	Candidate condition 1	Candidate condition 2	Candidate condition 3
Pr(Condition in population)	Pr(Condition 1 in population)	Pr(Condition 2 in population)	Pr(Condition 3 in population)
RRcondition	RR 1	RR 2	RR 3
Pr(Condition WHOIFPI)	Pr(Condition 1 WHOIFPI)	Pr(Condition 2 WHOIFPI)	P(Condition 3 WHOIFPI)
rCondition → presentation	rCondition 1 → presentation	rCondition 2 → presentation	rCondition 3 → presentation
Pr(Presentation WHOIFPI by condition)	Pr(Presentation WHOIFPI by condition 1)	Pr(Presentation WHOIFPI by condition 2)	Pr(Presentation WHOIFPI by condition 3)
Pr(Presentation WHOIFPI) = the sum of the probabilities in row just above
Pr(Presentation is caused by condition in individual)	Pr(Presentation is caused by condition 1 in individual)	Pr(Presentation is caused by condition 2 in individual)	Pr(Presentation is caused by condition 3 in individual)

One additional "candidate condition" is the instance of there being no abnormality, and the presentation is only a (usually relatively unlikely) appearance of a basically normal state. Its probability in the population (P(No abnormality in population)) is complementary to the sum of probabilities of "abnormal" candidate conditions.

Example

This example case demonstrates how this method is applied but does not represent a guideline for handling similar real-world cases. Also, the example uses relatively specified numbers with sometimes several decimals, while in reality, there are often simply rough estimations, such as of likelihoods being very high, high, low or very low, but still using the general principles of the method.

For an individual (who becomes the "patient" in this example), a blood test of, for example, serum calcium shows a result above the standard reference range, which, by most definitions, classifies as hypercalcemia, which becomes the "presentation" in this case. A clinician (who becomes the "diagnostician" in this example), who does not currently see the patient, gets to know about his finding.

By practical reasons, the clinician considers that there is enough test indication to have a look at the patient's medical records. For simplicity, let's say that the only information given in the medical records is a family history of primary hyperparathyroidism (here abbreviated as PH), which may explain the finding of hypercalcemia. For this patient, let's say that the resultant hereditary risk factor is estimated to confer a relative risk of 10 (RR_PH = 10).

The clinician considers that there is enough motivation to perform a differential diagnostic procedure for the finding of hypercalcemia. The main causes of hypercalcemia are primary hyperparathyroidism (PH) and cancer, so for simplicity, the list of candidate conditions that the clinician could think of can be given as:

• Primary hyperparathyroidism (PH)
• Cancer
• Other diseases that the clinician could think of (which is simply termed "other conditions" for the rest of this example)
• No disease (or no abnormality), and the finding is caused entirely by statistical variability

The probability that 'primary hyperparathyroidism' (PH) would have occurred in the first place in the individual (P(PH WHOIFPI)) can be calculated as follows:

Let's say that the last blood test taken by the patient was half a year ago and was normal and that the incidence of primary hyperparathyroidism in a general population appropriately matches the individual (except for the presentation and mentioned heredity) is 1 in 4000 per year. Ignoring more detailed retrospective analyses (such as including speed of disease progress and lag time of medical diagnosis), the time-at-risk for having developed primary hyperparathyroidism can roughly be regarded as being the last half-year because a previously developed hypercalcemia would probably have been caught up by the previous blood test. This corresponds to a probability of primary hyperparathyroidism (PH) in the population of:

${\displaystyle Pr(\text{PH in population})=0.5\text{ years}\cdot \frac{1}{\text{4000 per year}}=\frac{1}{8000}}$

With the relative risk conferred from the family history, the probability that primary hyperparathyroidism (PH) would have occurred in the first place in the individual given from the currently available information becomes:

${\displaystyle Pr(\text{PH WHOIFPI})\approx R{R}_{PH}\cdot Pr(\text{PH in population})=10\cdot \frac{1}{8000}=\frac{1}{800}=0.00125}$

Primary hyperparathyroidism can be assumed to cause hypercalcemia essentially 100% of the time (r_{PH → hypercalcemia} = 1), so this independently calculated probability of primary hyperparathyroidism (PH) can be assumed to be the same as the probability of being a cause of the presentation:

${\displaystyle \begin{array}{rl}Pr(\text{Hypercalcemia WHOIFPI by PH})& =Pr(\text{PH WHOIFPI})\cdot r_{\text{PH}\to \text{hypercalcemia}}\\ & =0.00125\cdot 1=0.00125\end{array}}$

For cancer, the same time-at-risk is assumed for simplicity, and let's say that the incidence of cancer in the area is estimated at 1 in 250 per year, giving a population probability of cancer of:

${\displaystyle Pr(\text{cancer in population})=0.5\text{ years}\cdot \frac{1}{\text{250 per year}}=\frac{1}{500}}$

For simplicity, let's say that any association between a family history of primary hyperparathyroidism and risk of cancer is ignored, so the relative risk for the individual to have contracted cancer in the first place is similar to that of the population (RR_cancer = 1):

${\displaystyle Pr(\text{cancer WHOIFPI})\approx R{R}_{\text{cancer}}\cdot Pr(\text{cancer in population})=1\cdot \frac{1}{500}=\frac{1}{500}=\mathrm{0.002.}}$

However, hypercalcemia only occurs in, very approximately, 10% of cancers, (r_{cancer → hypercalcemia} = 0.1), so:

${\displaystyle \begin{array}{rl}& Pr(\text{Hypercalcemia WHOIFPI by cancer})\\ =& Pr(\text{cancer WHOIFPI})\cdot r_{\text{cancer}\to \text{hypercalcemia}}\\ =& 0.002\cdot 0.1=\mathrm{0.0002.}\end{array}}$

The probabilities that hypercalcemia would have occurred in the first place by other candidate conditions can be calculated in a similar manner. However, for simplicity, let's say that the probability that any of these would have occurred in the first place is calculated at 0.0005 in this example.

For the instance of there being no disease, the corresponding probability in the population is complementary to the sum of probabilities for other conditions:

${\displaystyle \begin{array}{rl}Pr(\text{no disease in population})& =1-Pr(\text{PH in population})-Pr(\text{cancer in population})\\ & -Pr(\text{other conditions in population})\\ & =\mathrm{0.997.}\end{array}}$

The probability that the individual would be healthy in the first place can be assumed to be the same:

${\displaystyle Pr(\text{no disease WHOIFPI})=\mathrm{0.997.}}$

The rate at which the case of no abnormal condition still ends up in measurement of serum calcium of being above the standard reference range (thereby classifying as hypercalcemia) is, by the definition of standard reference range, less than 2.5%. However, this probability can be further specified by considering how much the measurement deviates from the mean in the standard reference range. Let's say that the serum calcium measurement was 1.30 mmol/L, which, with a standard reference range established at 1.05 to 1.25 mmol/L, corresponds to a standard score of 3 and a corresponding probability of 0.14% that such degree of hypercalcemia would have occurred in the first place in the case of no abnormality:

${\displaystyle r_{\text{no disease}\to \text{hypercalcemia}}=0.0014}$

Subsequently, the probability that hypercalcemia would have resulted from no disease can be calculated as:

${\displaystyle \begin{array}{rl}& Pr(\text{Hypercalcemia WHOIFPI by no disease})\\ =& Pr(\text{no disease WHOIFPI})\cdot r_{\text{no disease}\to \text{hypercalcemia}}\\ =& 0.997\cdot 0.0014\approx 0.0014\end{array}}$

The probability that hypercalcemia would have occurred in the first place in the individual can thus be calculated as:

${\displaystyle \begin{array}{rl}& Pr(\text{hypercalcemia WHOIFPI})\\ =& Pr(\text{hypercalcemia WHOIFPI by PH})+Pr(\text{hypercalcemia WHOIFPI by cancer})\\ & +Pr(\text{hypercalcemia WHOIFPI by other conditions})+Pr(\text{hypercalcemia WHOIFPI by no disease})\\ =& 0.00125+0.0002+0.0005+0.0014=0.00335\end{array}}$

Subsequently, the probability that hypercalcemia is caused by primary hyperparathyroidism (PH) in the individual can be calculated as:

${\displaystyle \begin{array}{rl}& Pr(\text{hypercalcemia is caused by PH in individual})\\ =& \frac{Pr(\text{hypercalcemia WHOIFPI by PH})}{Pr(\text{hypercalcemia WHOIFPI})}\\ =& \frac{0.00125}{0.00335}=0.373=37.3\mathrm{\%}\end{array}}$

Similarly, the probability that hypercalcemia is caused by cancer in the individual can be calculated as:

${\displaystyle \begin{array}{rl}& Pr(\text{hypercalcemia is caused by cancer in individual})\\ =& \frac{Pr(\text{hypercalcemia WHOIFPI by cancer})}{Pr(\text{hypercalcemia WHOIFPI})}\\ =& \frac{0.0002}{0.00335}=0.060=6.0\mathrm{\%},\end{array}}$

and for other candidate conditions:

${\displaystyle \begin{array}{rl}& Pr(\text{hypercalcemia is caused by other conditions in individual})\\ =& \frac{Pr(\text{hypercalcemia WHOIFPI by other conditions})}{Pr(\text{hypercalcemia WHOIFPI})}\\ =& \frac{0.0005}{0.00335}=0.149=14.9\mathrm{\%},\end{array}}$

and the probability that there actually is no disease:

${\displaystyle \begin{array}{rl}& Pr(\text{hypercalcemia is present despite no disease in individual})\\ =& \frac{Pr(\text{hypercalcemia WHOIFPI by no disease})}{Pr(\text{hypercalcemia WHOIFPI})}\\ =& \frac{0.0014}{0.00335}=0.418=41.8\mathrm{\%}\end{array}}$

For clarification, these calculations are given as the table in the method description:

	PH	Cancer	Other conditions	No disease
P(Condition in population)	0.000125	0.002	-	0.997
RRx	10	1	-	-
P(Condition WHOIFPI)	0.00125	0.002	-	-
rCondition →hypercalcemia	1	0.1	-	0.0014
P(hypercalcemia WHOIFPI by condition)	0.00125	0.0002	0.0005	0.0014
P(hypercalcemia WHOIFPI) = 0.00335
P(hypercalcemia is caused by condition in individual)	37.3%	6.0%	14.9%	41.8%

Thus, this method estimates that the probability that the hypercalcemia is caused by primary hyperparathyroidism, cancer, other conditions or no disease at all are 37.3%, 6.0%, 14.9%, and 41.8%, respectively, which may be used in estimating further test indications.

This case is continued in the example of the method described in the next section.

Likelihood ratio-based method

The procedure of differential diagnosis can become extremely complex when fully taking additional tests and treatments into consideration. One method that is somewhat a tradeoff between being clinically perfect and being relatively simple to calculate is one that uses likelihood ratios to derive subsequent post-test likelihoods.

Theory

The initial likelihoods for each candidate condition can be estimated by various methods, such as:

• By epidemiology as described in the previous section.
• By clinic-specific pattern recognition, such as statistically knowing that patients coming into a particular clinic with a particular complaint statistically has a particular likelihood of each candidate condition.

One method of estimating likelihoods even after further tests uses likelihood ratios (which is derived from sensitivities and specificities) as a multiplication factor after each test or procedure. In an ideal world, sensitivities and specificities would be established for all tests for all possible pathological conditions. In reality, however, these parameters may only be established for one of the candidate conditions. Multiplying with likelihood ratios necessitates conversion of likelihoods from probabilities to odds in favor (hereafter simply termed "odds") by:

${\displaystyle \text{odds}=\frac{\text{probability}}{1-\text{probability}}}$

However, only the candidate conditions with known likelihood ratio need this conversion. After multiplication, conversion back to probability is calculated by:

${\displaystyle \text{probability}=\frac{\text{odds}}{\text{odds}+1}}$

The rest of the candidate conditions (for which there is no established likelihood ratio for the test at hand) can, for simplicity, be adjusted by subsequently multiplying all candidate conditions with a common factor to again yield a sum of 100%.

The resulting probabilities are used for estimating the indications for further medical tests, treatments or other actions. If there is an indication for an additional test, and it returns with a result, then the procedure is repeated using the likelihood ratio of the additional test. With updated probabilities for each of the candidate conditions, the indications for further tests, treatments, or other actions change as well, and so the procedure can be repeated until an endpoint where there no longer is any indication for currently performing further actions. Such an endpoint mainly occurs when one candidate condition becomes so certain that no test can be found that is powerful enough to change the relative probability profile enough to motivate any change in further actions. Tactics for reaching such an endpoint with as few tests as possible includes making tests with high specificity for conditions of already outstandingly high-profile-relative probability, because the high likelihood ratio positive for such tests is very high, bringing all less likely conditions to relatively lower probabilities. Alternatively, tests with high sensitivity for competing candidate conditions have a high likelihood ratio negative, potentially bringing the probabilities for competing candidate conditions to negligible levels. If such negligible probabilities are achieved, the clinician can rule out these conditions, and continue the differential diagnostic procedure with only the remaining candidate conditions.

Example

This example continues for the same patient as in the example for the epidemiology-based method. As with the previous example of epidemiology-based method, this example case is made to demonstrate how this method is applied but does not represent a guideline for handling similar real-world cases. Also, the example uses relatively specified numbers, while in reality, there are often just rough estimations. In this example, the probabilities for each candidate condition were established by an epidemiology-based method to be as follows:

	PH	Cancer	Other conditions	No disease
Probability	37.3%	6.0%	14.9%	41.8%

These percentages could also have been established by experience at the particular clinic by knowing that these are the percentages for final diagnosis for people presenting to the clinic with hypercalcemia and having a family history of primary hyperparathyroidism.

The condition of highest profile-relative probability (except "no disease") is primary hyperparathyroidism (PH), but cancer is still of major concern, because if it is the actual causative condition for the hypercalcemia, then the choice of whether to treat or not likely means life or death for the patient, in effect potentially putting the indication at a similar level for further tests for both of these conditions.

Here, let's say that the clinician considers the profile-relative probabilities of being of enough concern to indicate sending the patient a call for a clinician visit, with an additional visit to the medical laboratory for an additional blood test complemented with further analyses, including parathyroid hormone for the suspicion of primary hyperparathyroidism.

For simplicity, let's say that the clinician first receives the blood test (in formulas abbreviated as "BT") result for the parathyroid hormone analysis and that it showed a parathyroid hormone level that is elevated relative to what would be expected by the calcium level.

Such a constellation can be estimated to have a sensitivity of approximately 70% and a specificity of approximately 90% for primary hyperparathyroidism. This confers a likelihood ratio positive of 7 for primary hyperparathyroidism.

The probability of primary hyperparathyroidism is now termed Pre-BT_PH because it corresponds to before the blood test (Latin preposition prae means before). It was estimated at 37.3%, corresponding to an odds of 0.595. With the likelihood ratio positive of 7 for the blood test, the post-test odds is calculated as:

${\displaystyle \mathrm{Odds}({\text{PostBT}}_{PH})=\mathrm{Odds}({\text{PreBT}}_{PH})\cdot LH(BT)=0.595\cdot 7=4.16,}$

where:

• Odds(PostBT_PH) is the odds for primary hyperparathyroidism after the blood test for parathyroid hormone
• Odds(PreBT_PH is the odds in favor of primary hyperparathyroidism before the blood test for parathyroid hormone
• LH(BT) is the likelihood ratio positive for the blood test for parathyroid hormone

An Odds(PostBT_PH) of 4.16 is again converted to the corresponding probability by:

${\displaystyle Pr({\text{PostBT}}_{PH})=\frac{\mathrm{Odds}({\text{PostBT}}_{PH})}{\mathrm{Odds}({\text{PostBT}}_{PH})+1}=\frac{4.16}{4.16+1}=0.806=80.6\mathrm{\%}}$

The sum of the probabilities for the rest of the candidate conditions should therefore be:

${\displaystyle Pr({\text{PostBT}}_{rest})=100\mathrm{\%}-80.6\mathrm{\%}=19.4\mathrm{\%}}$

Before the blood test for parathyroid hormone, the sum of their probabilities were:

${\displaystyle Pr({\text{PreBT}}_{\text{rest}})=6.0\mathrm{\%}+14.9\mathrm{\%}+41.8\mathrm{\%}=62.7\mathrm{\%}}$

Therefore, to conform to a sum of 100% for all candidate conditions, each of the other candidates must be multiplied by a correcting factor:

${\displaystyle \text{Correcting factor}=\frac{Pr({\text{PostBT}}_{\text{rest}})}{Pr({\text{PreBT}}_{\text{rest}})}=\frac{19.4}{62.7}=0.309}$

For example, the probability of cancer after the test is calculated as:

${\displaystyle Pr({\text{PostBT}}_{\text{cancer}})=Pr({\text{PreBT}}_{\text{cancer}})\cdot \text{Correcting factor}=6.0\mathrm{\%}\cdot 0.309=1.9\mathrm{\%}}$

The probabilities for each candidate conditions before and after the blood test are given in following table:

	PH	Cancer	Other conditions	No disease
P(PreBT)	37.3%	6.0%	14.9%	41.8%
P(PostBT)	80.6%	1.9%	4.6%	12.9%

These "new" percentages, including a profile-relative probability of 80% for primary hyperparathyroidism, underlie any indications for further tests, treatments, or other actions. In this case, let's say that the clinician continues the plan for the patient to attend a clinician visit for a further checkup, especially focused on primary hyperparathyroidism.

A clinician visit can, theoretically, be regarded as a series of tests, including both questions in a medical history, as well as components of a physical examination, where the post-test probability of a previous test, can be used as the pre-test probability of the next. The indications for choosing the next test are dynamically influenced by the results of previous tests.

Let's say that the patient in this example is revealed to have at least some of the symptoms and signs of depression, bone pain, joint pain or constipation of more severity than what would be expected by the hypercalcemia itself, supporting the suspicion of primary hyperparathyroidism, and let's say that the likelihood ratios for the tests, when multiplied together, roughly results in a product of 6 for primary hyperparathyroidism.

The presence of unspecific pathologic symptoms and signs in the history and examination are often concurrently indicative of cancer as well, and let's say that the tests gave an overall likelihood ratio estimated at 1.5 for cancer. For other conditions, as well as the instance of not having any disease at all, let's say that it is unknown how they are affected by the tests at hand, as often happens in reality. This gives the following results for the history and physical examination (abbreviated as P&E):

	PH	Cancer	Other conditions	No disease
P(PreH&E)	80.6%	1.9%	4.6%	12.9%
Odds(PreH&E)	4.15	0.019	0.048	0.148
Likelihood ratio by H&E	6	1.5	-	-
Odds(PostH&E)	24.9	0.0285	-	-
P(PostH&E)	96.1%	2.8%	-	-
Sum of known P(PostH&E)	98.9%
Sum of the rest P(PostH&E)	1.1%
Sum of the rest P(PreH&E)	4.6% + 12.9% = 17.5%
Correcting factor	1.1% / 17.5% = 0.063
After correction	-	-	0.3%	0.8%
P(PostH&E)	96.1%	2.8%	0.3%	0.8%

These probabilities after the history and examination may make the physician confident enough to plan the patient for surgery for a parathyroidectomy to resect the affected tissue.

At this point, the probability of "other conditions" is so low that the physician cannot think of any test for them that could make a difference that would be substantial enough to form an indication for such a test, and the physician thereby practically regards "other conditions" as ruled out, in this case not primarily by any specific test for such other conditions that were negative, but rather by the absence of positive tests so far.

For "cancer", the cutoff at which to confidently regard it as ruled out maybe more stringent because of severe consequences of missing it, so the physician may consider that at least a histopathologic examination of the resected tissue is indicated.

This case is continued in the example of Combinations in the corresponding section below.

Coverage of candidate conditions

The validity of both the initial estimation of probabilities by epidemiology and further workup by likelihood ratios are dependent on the inclusion of candidate conditions that are responsible for a large part as possible of the probability of having developed the condition, and it is clinically important to include those where relatively fast initiation of therapy is most likely to result in the greatest benefit. If an important candidate condition is missed, no method of differential diagnosis will supply the correct conclusion. The need to find more candidate conditions for inclusion increases with the increasing severity of the presentation itself. For example, if the only presentation is a deviating laboratory parameter and all common harmful underlying conditions have been ruled out, then it may be acceptable to stop finding more candidate conditions, but this would much more likely be unacceptable if the presentation would have been severe pain.

Combinations

If two conditions get high post-test probabilities, especially if the sum of the probabilities for conditions with known likelihood ratios becomes higher than 100%, then the actual condition is a combination of the two. In such cases, that combined condition can be added to the list of candidate conditions, and the calculations should start over from the beginning.

To continue the example used above, let's say that the history and physical examination were indicative of cancer as well, with a likelihood ratio of 3, giving an Odds(PostH&E) of 0.057, corresponding to a P(PostH&E) of 5.4%. This would correspond to a "Sum of known P(PostH&E)" of 101.5%. This is an indication for considering a combination of primary hyperparathyroidism and cancer, such as, in this case, a parathyroid hormone-producing parathyroid carcinoma. A recalculation may therefore be needed, with the first two conditions being separated into "primary hyperparathyroidism without cancer", "cancer without primary hyperparathyroidism" as well as "combined primary hyperparathyroidism and cancer", and likelihood ratios being applied to each condition separately. In this case, however, tissue has already been resected, wherein a histopathologic examination can be performed that includes the possibility of parathyroid carcinoma in the examination (which may entail appropriate sample staining). Let's say that the histopathologic examination confirms primary hyperparathyroidism, but also showed a malignant pattern. By an initial method by epidemiology, the incidence of parathyroid carcinoma is estimated at 1 in 6 million people per year, giving a very low probability before taking any tests into consideration. In comparison, the probability that non-malignant primary hyperparathyroidism would have occurred at the same time as an unrelated non-carcinoma cancer that presents with malignant cells in the parathyroid gland is calculated by multiplying the probabilities of the two. The resultant probability is, however, much smaller than the 1 in 6 million. Therefore, the probability of parathyroid carcinoma may still be close to 100% after histopathologic examination despite the low probability of occurring in the first place.

Machine differential diagnosis

Further information: Clinical decision support system

Machine differential diagnosis is the use of computer software to partly or fully make a differential diagnosis. It may be regarded as an application of artificial intelligence. Alternatively, it may be seen as "Augmented Intelligence" if it meets the FDA criteria, namely that (1) it reveals the underlying data, (2) reveals the underlying logic, and (3) leaves the clinician in charge to shape and make the decision. Machine Learning AI is generally seen as a device by the FDA, whereas Augmented Intelligence applications are not.

Many studies demonstrate improvement of quality of care and reduction of medical errors by using such decision support systems. Some of these systems are designed for a specific medical problem such as schizophrenia, Lyme disease or ventilator-associated pneumonia. Others are designed to cover all major clinical and diagnostic findings to assist physicians with faster and more accurate diagnosis.

However, these tools all still require advanced medical skills to rate symptoms and choose additional tests to deduce the probabilities of different diagnoses. Machine differential diagnosis is also currently unable to diagnose multiple concurrent disorders. Thus, non-professionals should still see a health care provider for a proper diagnosis.

History

The method of differential diagnosis was first suggested for use in the diagnosis of mental disorders by Emil Kraepelin. It is more systematic than the old-fashioned method of diagnosis by gestalt (impression).

Alternative medical meanings

'Differential diagnosis' is also used more loosely, to refer simply to a list of the most common causes of a given symptom, to a list of disorders similar to a given disorder, or to such lists when they are annotated with advice on how to narrow the list down (French's Index of Differential Diagnosis is an example). Thus, a differential diagnosis in this sense is medical information specially organized to aid in diagnosis.

Usage apart from in medicine

Methods similar to those of differential diagnostic processes in medicine are also used by biological taxonomists to identify and classify organisms, living and extinct. For example, after finding an unknown species, there can first be a listing of all potential species, followed by ruling out of one by one until, optimally, only one potential choice remains. Similar procedures may be used by plant and maintenance engineers and automotive mechanics and used to be used in diagnosing faulty electronic circuitry.

In popular culture

The American television medical drama House stars Hugh Laurie as the main protagonist Dr. Gregory House. He leads a team of diagnosticians at the fictional Princeton–Plainsboro Teaching Hospital in New Jersey, who regularly use differential diagnostics procedures in a bid to produce the right diagnosis. House uses provocation, humiliation and conflict to hone his team's minds and ignore preconceptions in an effort to extract inventive thinking.

Throughout the series, the doctors have diagnosed such diseases as lupus, mastocytosis, Plummer's disease, rabies, Kawasaki's syndrome, smallpox, Rickettsialpox, and dozens of others.

Idiopathic chronic fatigue

From Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Idiopathic_chronic_fatigue

 

Idiopathic Chronic Fatigue
Other names	Chronic Idiopathic Fatigue (CIF), insufficient/idiopathic fatigue (ISF), unexplained chronic fatigue
Specialty	Family medicine, Internal medicine, Musculoskeletal
Symptoms	Chronic fatigue
Usual onset	Acquired (not lifelong)
Duration	At least six consecutive months
Causes	Unknown
Diagnostic method	Based on symptoms. Diagnosis of exclusion requiring laboratory evaluation, physical and biopsychosocial assessment.
Differential diagnosis	Occupational burnout; chronic fatigue due to a known medical condition such as chronic fatigue syndrome, overtraining
Treatment	Symptomatic
Frequency	6.2 to 64.2 per 1000

Idiopathic chronic fatigue (ICF) or chronic idiopathic fatigue or insufficient/idiopathic fatigue is characterized by unexplained fatigue that lasts at least six consecutive months. which does not meet the criteria for chronic fatigue syndrome. It is widely understood to have a profound effect on the lives of patients who experience it.

ICF is a common illness of unknown origin, and remains poorly understood.

Classification

Idiopathic chronic fatigue does not have its dedicated diagnostic code in the World Health Organization's ICD-11 classification. ICF is defined as a physical medical condition of unknown origin where CFS symptoms are not met, and because the World Health Organization does not recognize any kind of fatigue-based psychiatric illness (unless it is accompanied by related psychiatric symptoms), this means that only the fatigue codes in the physical symptoms category of the ICD can be used. MG22 (Fatigue) and R53.8 (Other malaise and fatigue) codes in the ICD-11 and ICD-10 respectively both allow ICF to be coded as fatigue or unspecified chronic fatigue, and are used when no more specific codes exist. These codes help distinguish ICF from many other forms of fatigue including cancer-related fatigue, chronic fatigue syndrome, fatigue due to depression, fatigue due to old age, weakness/asthenia, and in the ICD-10, also from fatigue lasting under 6 months. The ICD-11 MG22 Fatigue code is also shared with lethargy, and exhaustion, which may not be as long lasting.

Diagnosis

ICF is fatigue of unknown origin, persisting or relapsing for a minimum of six consecutive months, and failing to meet the criteria for chronic fatigue syndrome. There are no agreed upon international criteria for idiopathic chronic fatigue, however the CDC's 1994 Idiopathic Chronic Fatigue criteria, known as the Fukuda ICF criteria, are commonly used.

Differential diagnosis

Differences from chronic fatigue

ICF differs from chronic fatigue since it is unexplained rather than linked to a medical or psychological illness (for example, diabetes or depression). This means that ICF patients have reduced treatment options: there is no underlying disease or known cause that could be treated in order to reduce the degree of fatigue, which results in a poorer prognosis for ICF.

In ICF, the fatigue lasts for a minimum of six months, but chronic fatigue is usually (but not always) considered to last for a minimum of six months to be considered chronic, and if lasting between one and six months it is considered prolonged fatigue.

Chronic fatigue is the term used when medical tests and a mental and physical assessment has not yet been carried out. ICF can only be diagnosed after these are done and the results show no underlying untreated cause.

Differences from neurasthenia

• Neurasthenia consists of a large number of symptoms, typically patients had a mix of physical and psychological complaints for example anxiety, stress-related headaches, heart palpitations, depressed mood, fatigue, lethargy, insomnia, restlessness and weariness. Fatigue was common but not essential. ICF consists of the single symptom of fatigue, which may be either mental or physical or both, and may be described in many different ways including as "exhaustion".

• ICF has no known cause, and psychological factors such as stress have been ruled out, but neurasthenia was believed to be caused by the stresses of the modern age and psychological or psychosocial factors were seen as important.
• Neurasthenia has been very rarely reported since the 21st century, and was deprecated in the World Health Organization's most recent International Classification of Diseases, known as the ICD-11. Neurasthenia had previously been categorized as a psychological illness, and originally as neurological. ICF is not psychological- the WHO does not have a classification for any fatigue-only psychiatric illness.

Differential diagnosis from chronic fatigue syndrome

• Chronic fatigue syndrome (CFS) requires the additional symptoms of:

1. post-exertional malaise (significantly worsening symptoms with activity which results in a significant reduction in daily activities, which may be delayed by up to 3 days
2. sleep dysfunction
3. either:

• • cognitive problems, or
  • orthostatic intolerance

A range of other symptoms commonly result from CFS including headaches, muscle and joint pain and low-grade fever

• ICF requires:

1. only one symptom: chronic fatigue
2. does not need a significant reduction in activities: some people are able to push through the fatigue to continue activities
3. is only diagnosed if CFS symptoms are not met

• Prevalence of ICF is between 3-15%, which is two to ten times higher than CFS
• Older age at onset is more common in ICF, particularly from age 50, while in CFS age at onset is typically 16-35 years old
• The recovery rate within a year is significantly higher for ICF patients, 30-50% compared to under 10% in CFS
• ICF is categorized within general signs and symptoms by the World Health Organization, while CFS is categorized as a neurological disease

Ability to tolerate exertion including exercise has been shown to be greater in ICF patients compared to CFS patients, particularly on consecutive days, and this applies to both men and women.

Severity of illness in ICF is typically less than in CFS, with some relatively small studies finding no severe ICF patients, the same studies found fibromyalgia was significantly less common in ICF.

Signs and symptoms

• Clinically evaluated fatigue
• New or definite onset (not lifelong)
• Fatigue persists or is relapsing for six consecutive months or longer
• Fails to meet the criteria for chronic fatigue syndrome
• The cause is unknown (not resulting from another medical condition)

Exclusions

• Fatigue which begins within 2 years of a substance use disorder (addiction) or at any time after
• Chronic fatigue syndrome
• fatigue caused by an active medical condition
• major depression with psychotic or melancholic features
• bipolar disorder
• schizophrenia or schizophrenia-related disorders
• delusional disorders
• the eating disorders anorexia nervosa and bulimia nervosa
• Occupational stress or other life stress and burnout
• Domestic violence
• fatigue caused as a known side effect of medication
• fatigue caused by a previous medical condition that may not be fully resolved

Common medical causes of fatigue

These must be ruled out before a diagnosis of ICF can be made.

• Infectious diseases including viruses and TB
• chronic fatigue syndrome
• Vascular diseases (affecting heart and circulation)
• Toxins and drug effects including poisons and substance use (addiction)
• Diseases affecting the lungs, including chronic obstructive pulmonary disease (COPD)
• Endocrine and metabolic problems, e.g., thyroid diseases and diabetes
• Diseases involving benign or cancerous tumours, including cancer fatigue
• Anaemia, Lupus and certain autoimmune or neurological diseases
• dementia (any form)
• severe obesity (a body mass index greater than 45)

Management

Idiopathic chronic fatigue is typically managed in general medicine rather than by referral to a specialist. There is no cure, no approved drug, and treatment options are limited. Management may involve a form of counseling, or antidepressant medication, although some patients may prefer herbal or alternative remedies.

Counseling

A form of counseling known as cognitive behavioral therapy may help some people manage or cope with idiopathic chronic fatigue.

Medication

There are no approved drugs for ICF.

Antidepressants

Antidepressants drugs such as tricyclic antidepressants (TCAs) or selective serotonin reuptake inhibitors (SSRIs) may be appropriate if symptoms are exacerbated by suspected or diagnosed serotonin related health issues, such as depression.

Alternative and complementary treatments

Only limited trials had been conducted for alternative and complementary treatments; there is no clear evidence of these treatments being effective for ICF due to a lack of randomized controlled trials.

Prognosis

Between 30% and just under 50% of patients recover within one year.

Epidemiology

Fatigue is common in the general population and often caused by overwork, too much activity or a specific illness or disease. Around 20% of patients who visit their clinician report fatigue. Prolonged fatigue is fatigue that persists for more than a month, and chronic fatigue is fatigue that lasts at least six consecutive months, which may be caused by a physical or psychological illness, or may be idiopathic (no known cause). Chronic fatigue with a known cause is twice as common as idiopathic chronic fatigue.

Idiopathic chronic fatigue affects between 2.4% and 6.42% of patients, with females more likely to be affected than men. Age at onset is typically over 50 years of age. A significant number of patients present with idiopathic chronic fatigue as part of a mix of medically unexplained symptoms, while others present with a primary problem of fatigue alone.